Skip to main content
. Author manuscript; available in PMC: 2019 Jul 26.
Published in final edited form as: Am J Nephrol. 2018 Jul 26;48(1):36–45. doi: 10.1159/000491023

Table 4b.

Associations of atrial fibrillation with all-cause and cause-specific mortality among those with proteinuria data (N = 30,143)

Unadjusted
HR (95% CI)
p-
value
Adjusted*
HR (95% CI)
p-
value
All-cause death 1.67 (1.57, 1.78) <0.001 1.24 (1.16, 1.32) <0.001
SHR (95% CI) SHR (95% CI)
Cardiovascular mortality^ 2.26 (2.06, 2.47) <0.001 1.45 (1.31, 1.61) <0.001
Malignancy-related mortality^ 0.91 (0.79, 1.04) 0.17 0.91 (0.78, 1.07) 0.24
Non-cardio non-malignancy
mortality^
1.33 (1.19, 1.47) <0.001 1.08 (0.96, 1.21) 0.21
Cardiovascular sub-categories
Ischemic heart disease^ 2.03 (1.78, 2.32) <0.001 1.28 (1.10, 1.48) 0.001
Heart failure^ 2.63 (1.94, 3.56) <0.001 1.22 (0.86, 1.73) 0.22
Cerebrovascular disease^ 1.73 (1.30, 2.29) <0.001 1.30 (0.95, 1.78) 0.10
Other cardiovascular diseases^ 2.35 (2.00, 2.76) <0.001 1.69 (1.40, 2.03) <0.001
*

adjusted for age, sex, race, diabetes, hyperlipidemia, body mass index, albumin, hemoglobin, malignancy (except in analysis excluding patients with baseline malignancy), hypertension, coronary artery disease, congestive heart failure, cerebrovascular disease, peripheral vascular disease, insurance type, ACE/ARB, beta blocker use, statins use, smoking, eGFR and proteinuria

Hazard and sub-hazard ratios presented in adjusted models were pooled using MIanalyze from 5 multiply imputed datasets;

^

N = 30,033 due to some missing cause of death.